How can we reduce the burden of cancer?
Implementing the research agenda of the National Cancer Institute’s Cancer Epidemiology and Genetics Program
Challenge
Scientists at the National Cancer Institute’s (NCI’s) Division of Cancer Epidemiology and Genetics (DCEG) work to understand genetic and environmental determinants of cancer. They study many different types of cancer, employ a wide range of study designs and collect a broad array of epidemiologic and clinical data, as well as biological and environmental samples.
These complex, multidisciplinary studies need considerable infrastructure and resources for successful conduct, such as clinical staff and experts in the collection and handling of biological and environmental samples. For many of DCEG’s longitudinal cohort studies, expertise is needed in long-term followup methods and linking cohorts to disease and death registries. Most studies require acquiring, editing, merging, and harmonizing data from multiple sources sometimes collected over the course of many years; maintaining the data in secure databases; and preparing analytic datasets.
Solution
For more than 40 years, Westat has provided research support services to DCEG investigators. We currently hold 4 task order contracts supporting 5 branches within the Division.
Our large and highly skilled workforce has advanced, specialized capabilities in
- Multimode data collection from individuals and healthcare delivery sources
- Clinical data collection
- Biological and environmental sample collection and management
- Exposure assessment
- Geospatial analysis
- Data linkages
- Management of complex biomedical data from multiple sources
We successfully manage multiple studies conducted concurrently and respond quickly to address newly emerging scientific questions. Many of the studies we support are international, and we have effectively negotiated subcontracts and monitored research activities on every continent, including in low- and middle-income countries.
Results
Westat is proud to support research that has made major contributions to our understanding of the causes, progression, prevention, and detection of cancer. Examples include studies that have identified genetic mutations associated with cancer in high-risk individuals, studies to understand the associations of infections with cancer and progression from precancerous lesions, and studies to understand the interrelationships between environmental and genetic factors in cancer.
-
Perspective
Workforce Development Drives Solutions to Rural Healthcare ShortagesDecember 2025
Rural communities face disproportionate shortages of healthcare professionals, resulting in diminished access to care, longer wait times, fewer available services, and, ultimately, poorer health outcomes.…
-
Expert Interview
Responsible Synthetic Data: Unlocking Insights While Safeguarding PrivacyDecember 2025
From electronic health records (EHRs) to federal statistics, synthetic data are rapidly transforming how organizations share and analyze information, offering new ways to unlock insights…
-
Expert Interview
Moving AHEAD by Overcoming Potential Challenges to Healthcare TransformationNovember 2025
Healthcare access and costs in the U.S. continue to move in opposite directions—access is declining while costs keep rising. Americans need innovative solutions that tackle…